Tomoko Betsuyaku

10.8k total citations
254 papers, 8.1k citations indexed

About

Tomoko Betsuyaku is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Tomoko Betsuyaku has authored 254 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Pulmonary and Respiratory Medicine, 56 papers in Molecular Biology and 49 papers in Epidemiology. Recurrent topics in Tomoko Betsuyaku's work include Chronic Obstructive Pulmonary Disease (COPD) Research (67 papers), Respiratory Support and Mechanisms (31 papers) and Mycobacterium research and diagnosis (27 papers). Tomoko Betsuyaku is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (67 papers), Respiratory Support and Mechanisms (31 papers) and Mycobacterium research and diagnosis (27 papers). Tomoko Betsuyaku collaborates with scholars based in Japan, United States and China. Tomoko Betsuyaku's co-authors include Masaharu Nishimura, Yasuyuki Nasuhara, Robert M. Senior, Yoko Ito, Katsura Nagai, Koichiro Asano, Kenzo Soejima, Koichi Fukunaga, Hironi Makita and Makoto Ishii and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Tomoko Betsuyaku

251 papers receiving 8.0k citations

Peers

Tomoko Betsuyaku
Comparison fields: 5 of 154
  • Pulmonary and Respiratory Medicine 3.9k
  • Molecular Biology 2.0k
  • Physiology 1.7k
  • Immunology 1.6k
  • Oncology 1.2k
Farrah Kheradmand United States
Jesse Roman United States
Darryl A. Knight Australia
Bruno Crestani France
Tomoaki Hoshino Japan
Fiorella Calabrese Italy
Shoji Kudoh Japan
Caroline A. Owen United States
Takafumi Suda Japan
Paul N. Reynolds Australia
Farrah Kheradmand United States View profile →
Citations per field, relative to Tomoko Betsuyaku
Tomoko Betsuyaku · 1×
Citations per year, relative to Tomoko Betsuyaku
Tomoko Betsuyaku · 1×

Countries citing papers authored by Tomoko Betsuyaku

Since Specialization
Citations

This map shows the geographic impact of Tomoko Betsuyaku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Betsuyaku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Betsuyaku more than expected).

Fields of papers citing papers by Tomoko Betsuyaku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Betsuyaku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Betsuyaku. The network helps show where Tomoko Betsuyaku may publish in the future.

Co-authorship network of co-authors of Tomoko Betsuyaku

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Betsuyaku. A scholar is included among the top collaborators of Tomoko Betsuyaku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Betsuyaku. Tomoko Betsuyaku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Risk factors for poor adherence to inhaled corticosteroid therapy in patients with moderate to severe asthma Asian Pacific Journal of Allergy and Immunology Katsunori Masaki, Jun Miyata et al. 5
2 Exposure to Cigarette Smoke Enhances the Stemness of Alveolar Type 2 Cells American Journal of Respiratory Cell and Molecular Biology Akihiro Tsutsumi, Mari Ozaki et al. 19
3 Pharmacological and Structural Characterizations of Naquotinib, a Novel Third-Generation EGFR Tyrosine Kinase Inhibitor, in EGFR -Mutated Non–Small Cell Lung Cancer Molecular Cancer Therapeutics Toshiyuki Hirano, Hiroyuki Yasuda et al. 31
4 Tumor associated macrophages support the growth of FGF9-induced lung adenocarcinoma by multiple mechanisms Lung Cancer Ahmed E. Hegab, Mari Ozaki et al. 27
5 Amplification of EGFR Wild-Type Alleles in Non–Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors Cancer Research Shigenari Nukaga, Hiroyuki Yasuda et al. 131
6 Overcoming EGFR Bypass Signal-Induced Acquired Resistance to ALK Tyrosine Kinase Inhibitors in ALK-Translocated Lung Cancer Molecular Cancer Research Masayoshi Miyawaki, Hiroyuki Yasuda et al. 58
7 Activation of EGFR Bypass Signaling by TGFα Overexpression Induces Acquired Resistance to Alectinib in ALK -Translocated Lung Cancer Cells Molecular Cancer Therapeutics Tetsuo Tani, Hiroyuki Yasuda et al. 54
8 ランゲリン/CD207のケラタン硫酸二糖,Gal(6SO 3 )β1,4-GlcNAc(6SO 3 )とそのトライアングル誘導体へのin vitroおよびin vivoでの結合:COPD(慢性閉塞性肺疾患)の創薬標的候補 Glycobiology Reiko Fujinawa, Congxiao Gao et al. 2
9 Binding of langerin/CD207 to keratan sulfate disaccharide, Gal (6SO3) β1, 4-GlcNAc (6SO3) and its triangle derivative in vitro and in vivo: possible drug targets for COPD (chronic obstructive pulmonary disease) Max Planck Digital Library Reiko Fujinawa, Congxiao Gao et al. 1
10 Rapid Induction of Lung Adenocarcinoma by Fibroblast Growth Factor 9 Signaling through FGF Receptor 3 Cancer Research Yongjun Yin, Tomoko Betsuyaku et al. 46
11 Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC Molecular Cancer Research Hideki Terai, Kenzo Soejima et al. 174
12 Discovery of candidate proteins, PIGR and SELENBP1, as novel markers of airway diseases in COPD European Respiratory Journal Hidetoshi Nakamura, Miho Nakamura et al. 1
13 Epilysin (MMP-28) Restrains Early Macrophage Recruitment in Pseudomonas aeruginosa Pneumonia The Journal of Immunology Anne M. Manicone, Timothy P. Birkland et al. 72
14 Dual Oxidase 1 and 2 Expression in Airway Epithelium of Smokers and Patients with Mild/Moderate Chronic Obstructive Pulmonary Disease Antioxidants and Redox Signaling Katsura Nagai, Tomoko Betsuyaku et al. 44
15 A Case of Squamous Cell Carcinoma of the Lung Preceded by Pulmonary Aspergillosis Haigan Nao Odajima, Koichi Yamazaki et al. 2
16 Neutrophil Granule Proteins in Bronchoalveolar Lavage Fluid from Subjects with Subclinical Emphysema American Journal of Respiratory and Critical Care Medicine Tomoko Betsuyaku, Masaharu Nishimura et al. 189
17 Elastin-Derived Peptides and Neutrophil Elastase in Bronchoalveolar Lavage Fluid American Journal of Respiratory and Critical Care Medicine Tomoko Betsuyaku, Masaharu Nishimura et al. 26
18 Neutrophil Elastase Associated with Alveolar Macrophages from Older Volunteers American Journal of Respiratory and Critical Care Medicine Tomoko Betsuyaku, Aya Yoshioka et al. 20
19 Excessive Neutrophil Elastase in Bronchoalveolar Lavage Fluid in Subclinical Emphysema American Journal of Respiratory and Critical Care Medicine Aya Yoshioka, Tomoko Betsuyaku et al. 48
20 Establishing Diagnosis of Pulmonary Malignant Lymphoma by Gene Rearrangement Analysis of Lymphocytes in Bronchoalveolar Lavage Fluid American Journal of Respiratory and Critical Care Medicine Tomoko Betsuyaku, M. Munakata et al. 30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026